This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
French tarragon contains volatile oils including estragole, ocimene, and terpinolene, which act as carminatives to relieve digestive discomfort. These compounds help relax smooth muscle in the gastrointestinal tract through antispasmodic activity, reducing cramping and bloating. The herb also stimulates digestive secretions to improve overall digestion. Evidence level: C (preliminary clinical evidence and traditional use support this mechanism).
Does French tarragon interact with any medications?
French tarragon has no well-documented drug interactions in current literature. However, due to limited research, caution is advised when taking blood thinners, as the herb contains compounds that may theoretically affect clotting. The estragole content has raised theoretical concerns about liver enzyme interactions. Always consult a healthcare provider before combining herbs with prescription medications. Evidence level: D (insufficient evidence for interactions).
What is the recommended dosage for French tarragon?
The standard adult dosage for French tarragon is 2-4 grams of dried herb daily, typically prepared as a tea or used in culinary applications. This amount provides therapeutic benefits while staying within safe consumption limits. Higher doses should be avoided due to estragole content. For tea, steep 1-2 teaspoons of dried herb in hot water for 10-15 minutes. Evidence level: C (traditional use with some clinical guidance).
Is French tarragon safe during pregnancy?
French tarragon is considered unsafe during pregnancy and should be avoided in medicinal amounts. The herb contains estragole, which has demonstrated potential carcinogenic and genotoxic effects in animal studies. High doses may stimulate uterine contractions and affect menstrual cycles. Pregnant women, those trying to conceive, and breastfeeding mothers should not use medicinal doses. Culinary amounts in food are generally considered acceptable. Evidence level: C.
What is French tarragon used for medicinally?
French tarragon has been used in European folk medicine primarily as a digestive stimulant and carminative to relieve bloating, gas, and stomach cramps. It also has traditional use for menstrual regulation and as an antispasmodic for muscle cramps. The herb contains antioxidant compounds like rutin. While these uses are well-established in traditional medicine, clinical evidence remains limited. Evidence level: C (preliminary evidence supporting traditional uses).
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Artemisia dracunculus (tarragon) is a perennial herb used as a spice and traditional remedy with documented anti-inflammatory, analgesic, and antimicrobial properties [PMID:33927629, PMID:21942448].
Background
Artemisia dracunculus L., belonging to the Asteraceae family, is a species utilized as a spice and medicinal herb across Asia, Europe, and the Americas [PMID:33927629, PMID:21942448]. Two primary cultivars, Russian and French, are widely used and differ in morphology, ploidy level, and chemical composition [PMID:21942448].
Traditional uses
In traditional Asian medicine (particularly in Iran, Pakistan, Azerbaijan, and India), it is used to treat digestive system diseases and as an analgesic, hypnotic, antiepileptic, anti-inflammatory, antipyretic agent, and remedy for helminthiasis [PMID:33927629].
Active compounds
Key bioactive secondary metabolites include essential oils (containing estragole, methyleugenol, eugenol, beta-cis-ocimene, beta-trans-ocimene, and l-limonene), flavonoids (such as kaempferol), phenolic acids, coumarins (including 5,7-Dihydroxy-4-Methylcoumarin and herniarine), and alkamides (such as pellitorine, neopellitorine A, and neopellitorine B) [PMID:33927629, PMID:21942448, PMID:11730872, PMID:38068651, PMID:33746262, PMID:39800268, PMID:36082856].
Mechanism of action
The herb exhibits antioxidant and anti-inflammatory effects by inhibiting reactive oxygen species (ROS), interleukin 8 (IL-8), and tumour necrosis factor α (TNF-α) [PMID:32903580]. Specific compounds like 5,7-Dihydroxy-4-Methylcoumarin may ameliorate osteoporosis via the AKT1 pathway [PMID:39800268]. Certain alkamides act as inhibitors of α-melanocyte-stimulating hormone (α-MSH) induced melanin production [PMID:21821921] and as cytochrome P450 (CYP3A4) inhibitors [PMID:22738981].
Clinical evidence
Evidence CInflammation and Pain
Pharmacological studies have confirmed anti-inflammatory and analgesic effects [PMID:33927629].
Evidence DHyperglycemia/Diabetes
In vivo rodent studies highlight potential antihyperglycemic effects [PMID:21942448]; specific extracts (PMI5011) improve blood glucose and insulin sensitivity via skeletal muscle [PMID:37686232].
Evidence DAutoimmune Encephalomyelitis (EAE)
Aqueous extract (500 mg/kg) significantly ameliorated clinical scores of EAE in mice [PMID:32245296].
Evidence DOsteoporosis
The compound 5,7-Dihydroxy-4-Methylcoumarin enhances osteoblastogenesis and ameliorates glucocorticoid-induced osteoporosis in zebrafish models [PMID:39800268].
Evidence CNeuropathic Pain
Identified as a plant that exhibits protective effects on neuropathic pain [PMID:29796216].
Safety & adverse effects
Concerns exist regarding the hepatocarcinogenicity of estragole and methyleugenol [PMID:21942448, PMID:11077188, PMID:27761422]. However, no acute toxicity or mutagenic activity has been reported at doses relevant for human consumption, and water extracts are considered low risk [PMID:21942448]. One case report noted a life-threatening glottal edema in a patient with pre-existing sunflower allergy who showed strong sensitization against mugwort and tarragon [PMID:16285482].
Drug interactions
Alkamides from A. dracunculus have been identified as effective dose-dependent inhibitors of cytochrome P450 3A4 (CYP3A4) activity [PMID:22738981].
Evidence summary
The evidence is primarily based on in vitro studies, animal models (rodents, zebrafish), and literature reviews. There is a lack of human clinical trials to establish standardized therapeutic dosages and efficacy.
PubMed sources
1.PMID: 33927629 (2021) — Artemisia dracunculus (Tarragon): A Review of Its Traditional Uses, Phytochemistry and Pharmacology. · Frontiers in pharmacology
2.PMID: 23010670 (2013) — Toxicological and mutagenic analysis of Artemisia dracunculus (tarragon) extract. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
3.PMID: 21942448 (2011) — Artemisia dracunculus L. (tarragon): a critical review of its traditional use, chemical composition, pharmacology, and safety. · Journal of agricultural and food chemistry
4.PMID: 11730872 (2001) — Alkamides from Artemisia dracunculus. · Phytochemistry
5.PMID: 40863944 (2025) — Effects of Tarragon Hydrodistillate and Essential Oil on Aquatic Ecosystems.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 37112055 (2023) — Studies of the Tarragon Essential Oil Effects on the Characteristics of Doped Hydroxyapatite/Chitosan Biocomposites. · Polymers
7.PMID: 38247749 (2023) — Antimicrobial Activity of Artemisia dracunculus Oil-Loaded Agarose/Poly(Vinyl Alcohol) Hydrogel for Bio-Applications. · Gels (Basel, Switzerland)
8.PMID: 37686232 (2023) — Extract of Artemisia dracunculus L. Modulates Osteoblast Proliferation and Mineralization. · International journal of molecular sciences
9.PMID: 36234965 (2022) — Artemisia Species with High Biological Values as a Potential Source of Medicinal and Cosmetic Raw Materials. · Molecules (Basel, Switzerland)
10.PMID: 32234442 (2020) — Effect of chitosan-whey protein isolated coatings incorporated with tarragon Artemisia dracunculus essential oil on the quality of Scomberoides commersonnianus fillets at refrigerated condition. · International journal of biological macromolecules
11.PMID: 39199260 (2024) — Phytochemical Composition Antioxidant and Anti-Inflammatory Activity of Artemisia dracunculus and Artemisia abrotanum. · Antioxidants (Basel, Switzerland)
12.PMID: 39800268 (2025) — 5,7-Dihydroxy-4-Methylcoumarin enhances osteogenesis and ameliorates osteoporosis via the AKT1 pathway. · Biochemical pharmacology
13.PMID: 21821921 (2011) — Melanin biosynthesis inhibitors from Tarragon Artemisia dracunculus. · Bioscience, biotechnology, and biochemistry
14.PMID: 22738981 (2012) — Effective cytochrome P450 (CYP) inhibitors isolated from tarragon (Artemisia dracunculus). · Bioscience, biotechnology, and biochemistry
15.PMID: 19913108 (2010) — Risk assessment of consumption of methylchavicol and tarragon: the genotoxic potential in vivo and in vitro. · Mutation research
16.PMID: 32903580 (2020) — Inhibition of Neutrophil Functions and Antibacterial Effects of Tarragon (Artemisia dracunculus L.) Infusion-Phytochemical Characterization. · Frontiers in pharmacology
17.PMID: 28729836 (2017) — An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes. · Frontiers in pharmacology
18.PMID: 29796216 (2018) — Medicinal herbs in the treatment of neuropathic pain: a review. · Iranian journal of basic medical sciences
19.PMID: 18555848 (2008) — Strategies for assessment of botanical action on metabolic syndrome in the mouse and evidence for a genotype-specific effect of Russian tarragon in the regulation of insulin sensitivity. · Metabolism: clinical and experimental
20.PMID: 11077188 (2000) — Constituents of aromatic plants: II. Estragole. · Fitoterapia
21.PMID: 36082856 (2022) — Anticancer Properties of Kaempferol on Cellular Signaling Pathways. · Current topics in medicinal chemistry
22.PMID: 16285482 (2003) — [Occupational allergy to mugwort]. · Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
23.PMID: 27761422 (2016) — Estragole and methyl-eugenol-free extract of Artemisia dracunculus possesses immunomodulatory effects. · Avicenna journal of phytomedicine
24.PMID: 32245296 (2019) — The Effect of Aqueous Extract of Tarragon on Clinical Symptoms and T Cell Differentiation in Experimental Autoimmune Encephalomyelitis. · Iranian journal of allergy, asthma, and immunology
25.PMID: 35161282 (2022) — Characterization of Ingredients Incorporated in the Traditional Mixed-Salad of the Capuchin Monks. · Plants (Basel, Switzerland)
26.PMID: 31815461 (2019) — The DESIGNER Approach Helps Decipher the Hypoglycemic Bioactive Principles of Artemisia dracunculus (Russian Tarragon). · Journal of natural products
27.PMID: 38068651 (2023) — Unraveling the Potential of Organic Oregano and Tarragon Essential Oils: Profiling Composition, FT-IR and Bioactivities. · Plants (Basel, Switzerland)
28.PMID: 28193253 (2017) — Artemisia spp. essential oils against the disease-carrying blowfly Calliphora vomitoria. · Parasites & vectors
29.PMID: 33746262 (2021) — Preparation and evaluation of food-grade nanoemulsion of tarragon (Artemisia dracunculus L.) essential oil: antioxidant and antibacterial properties. · Journal of food science and technology
30.PMID: 37574459 (2023) — Extraction of Functional Compounds from Tarragon (Artemisia dracunculus L.) by Deep Eutectic Solvents at Different Properties. · Chemistry & biodiversity